Stacy Moulder
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
- Oncology 39
- Cancer-related Molecular Pathways 15
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 9
-
- Advanced Breast Cancer Therapies 23
- Co-authors
- Hope S. Rugo (5 shared papers)Dongrui R. Lu (4 shared papers)Richard S. Finn (4 shared papers)Véronique Dièras (4 shared papers)Karen A. Gelmon (4 shared papers)Miguel Martín (3 shared papers)Seock‐Ah Im (3 shared papers)Oleg Lipatov (3 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Clinical Cancer Research (8 papers)Cancer Research (7 papers)Molecular Cancer Therapeutics (3 papers)Annals of Oncology (3 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stacy Moulder
68 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Cancer Research 1.6k
- Oncology 2.7k
- Pulmonary and Respiratory Medicine 2.6k
- Genetics 705
- Molecular Biology 1.7k
Countries citing papers authored by Stacy Moulder
This map shows the geographic impact of Stacy Moulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy Moulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy Moulder more than expected).
Fields of papers citing papers by Stacy Moulder
This network shows the impact of papers produced by Stacy Moulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy Moulder. The network helps show where Stacy Moulder may publish in the future.
Co-authors
The 25 scholars most cited alongside Stacy Moulder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Palbociclib and Letrozole in Advanced Breast Cancer Hit paper breakdown → | 2016 | 1873 |
| 2 | Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes Hit paper breakdown → | 2021 | 413 |
| 3 | 2012 | 373 | |
| 4 | 2011 | 289 | |
| 5 | 2014 | 193 | |
| 6 | 2020 | 99 | |
| 7 | 2016 | 81 | |
| 8 | 2021 | 80 | |
| 9 | 2009 | 74 | |
| 10 | 2012 | 72 | |
| 11 | 2018 | 69 | |
| 12 | 2017 | 67 | |
| 13 | 2015 | 64 | |
| 14 | 2013 | 63 | |
| 15 | 2015 | 56 | |
| 16 | 2014 | 51 | |
| 17 | 2014 | 47 | |
| 18 | 2014 | 45 | |
| 19 | 2015 | 44 | |
| 20 | 2011 | 42 |
About Stacy Moulder
Stacy Moulder is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Genetics, having authored 70 papers that have together received 4.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (23 papers), Cancer-related Molecular Pathways (15 papers), Cancer Genomics and Diagnostics (14 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), HER2/EGFR in Cancer Research (12 papers), Breast Cancer Treatment Studies (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.7k citations), Pulmonary and Respiratory Medicine (2.6k citations), Genetics (705 citations) and Molecular Biology (1.7k citations). Stacy Moulder has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hope S. Rugo, Dongrui R. Lu, Richard S. Finn, Véronique Dièras, Karen A. Gelmon, Miguel Martín, Seock‐Ah Im, Oleg Lipatov, Nadia Harbeck and Janice M. Walshe. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, Molecular Cancer Therapeutics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.